Drug therapy in Alzheimer's disease [5] (multiple letters)

New England Journal of Medicine

Volumn 351, Issue 18, 2004, Pages 1911-1913

  De La Torre, Jack ^a   Aliev, Gjumrakch ^a   Perry, George ^a   Finucane, Thomas E ^b   Meyer, Michael A ^c   Cummings, Jeffrey L ^d  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

^c JACOBS NEUROLOGICAL INSTITUTE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; BENZODIAZEPINE RECEPTOR; CHOLINESTERASE INHIBITOR; DONEPEZIL; INDAN DERIVATIVE; PIPERIDINE DERIVATIVE;

ALZHEIMER DISEASE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG MECHANISM; HUMAN; LETTER; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; BIOSYNTHESIS; METABOLISM; NOTE; DIFFERENTIAL DIAGNOSIS; HYDROCEPHALUS; COST BENEFIT ANALYSIS; PRACTICE GUIDELINE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; HUMANS; CHOLINESTERASE INHIBITORS; DIAGNOSIS, DIFFERENTIAL; HYDROCEPHALUS; COST-BENEFIT ANALYSIS; INDANS; PIPERIDINES; PRACTICE GUIDELINES;

EID: 19644374309     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200410283511822     Document Type: Letter

References (0)